Global Demands For Generic Sartans Brought Explosive Growth To China’s API Market
This article was originally published in PharmAsia News
Executive Summary
With the current and incoming expiration of sartan patents, the global demand for generics grew quickly, which resulted in significant growth of China’s API market.